Poland reported 119 mpox cases between 1 January and 15 November 2026, compared with 22 over the same period in 2025. The Polish National Institute of Public Health (NIZP PZH) and Chief Sanitary Inspectorate (GIS) reported an incidence of 0.32 cases per 100,000 residents for the 2026 period. These are cumulative notifications, not infections acquired in a single week.

For most visitors, the practical question is whether they had relevant close contact with an infected person. The ECDC assesses risk to the general EU/EEA population as low for clade Ib and very low for clade IIb, while noting higher risk in some networks of close contacts. This population-wide assessment does not replace individual medical advice.

What the figures show—and what they do not

The previous Polish report listed 91 cases through 31 October 2026. The difference of 28 between reports is a change in cumulative notifications; it does not establish when all those infections occurred. Figures may also be revised as reports are checked. The November ECDC update identified 219 reported clade I cases across 15 EU/EEA countries in October, fewer than in September; international counts cover different periods and classifications.

Mpox spreads mainly through close physical contact, including contact with infected skin lesions, mucous membranes or contaminated materials. Sexual contact is one setting in which transmission may occur, but risk depends on actual exposure, not nationality or identity. Merely being in the same city as a person with mpox is not evidence of exposure.

Symptoms during a visit to Poland

Symptoms may include painful or itchy skin lesions, blisters or pustules, sores in the mouth or genital/anal area, fever, swollen lymph nodes, headache and muscle pain. A person may have only a few lesions. Poland’s Health Ministry describes an incubation period usually around 6–13 days, sometimes up to 21 days. Several other illnesses can produce similar symptoms; diagnosis requires professional assessment.

If you develop suggestive symptoms, avoid close skin-to-skin and sexual contact while seeking medical advice. Inform a clinic about symptoms before arriving, so it can arrange an appropriate consultation. Testing is generally based on PCR from a lesion when one is present.

Where visitors can seek help

If you are visiting Poland: Contact the clinic before attending in person and tell staff about a possible mpox exposure or symptoms. The local district sanitary-epidemiological station is called a powiatowa stacja sanitarno-epidemiologiczna (PSSE, often called sanepid). Find offices in the official GIS directory. For a life-threatening emergency in Poland, call 112 (or medical emergency 999). Emergency numbers are for emergencies, not routine questions.

For medically necessary, unplanned care during a temporary stay, visitors covered under the relevant EU/EFTA/UK arrangements can present a valid EHIC (or applicable substitute document) at an NFZ-contracted public provider. Coverage follows Polish public-system rules; it does not automatically cover private clinics, elective vaccination or every test. Check the NFZ guidance in English. Other visitors should check insurance and any charge with the provider; clinical assessment should not be delayed over billing questions in an emergency.

For practical details, read what to do after close contact, vaccination eligibility in Poland, PCR testing and precautions in a hotel or home.

Epidemiological data through 15 November 2026; guidance reviewed 21 November 2026. Official medical and sanitary instructions for your individual case take priority.